Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

Cutsem, E. van; Dicato, M.; Arber, N.; Berlin, J.; Cervantes, A.; Ciardiello, F.; ... ; Tabernero, J. (2010)

Article / Letter to editor

• phase-iii trial fluorouracil-based chemotherapy randomized controlled-trial advanced pancreatic-cancer cetuximab plus irinotecan microsatellite instability thymidylate synthase carcinoembryonic antigen combination chemotherapy 1st-line treatment

• All authors: Cutsem, E. van; Dicato, M.; Arber, N.; Berlin, J.; Cervantes, A.; Ciardiello, F.; Gramont, A. de; Diaz-Rubio, E.; Ducreux, M.; Geva, R.; Glimelius, B.; Jones, R.G.; Grothey, A.; Gruenberger, T.; Haller, D.; Haustermans, K.; Labianca, R.; Lenz, H.J.; Minsky, B.; Nordlinger, B.; Ohtsu, A.; Pavlidis, N.; Rougier, P.; Schmiegel, W.; Velde, C. van de; Schmoll, H.J.; Sobrero, A.; Tabernero, J.
• Date: 2010-12-31
• Journal: Annals of Oncology
• Volume: 21
• Pages: 1 - 10